Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19
NCT04467047
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Sars-CoV2
Interventions
BIOLOGICAL:
Mesenchymal Stromal Cells infusion
Sponsor
Hospital de Clinicas de Porto Alegre